Glaxosmithkline | 应收帐款人

Trade Debtors 更改 日
AbbVie USD 11.95B 537M 2024-03
Amgen USD 6.78B 492M 2024-03
AstraZeneca USD 12B 65M 2023-09
Aurora Cannabis CAD 43.32M 3.6M 2023-12
Bausch Health Companies USD 2.05B 50M 2024-03
Bristol-Myers Squibb USD 14.06B 1.59B 2024-03
Canopy Growth CAD 51.85M 12.08M 2024-03
Catalent USD 1.41B 85M 2024-03
Corcept Therapeutics USD 61.52M 20.4M 2024-03
Drreddys Laboratories INR 82.17B 11.36B 2023-12
Eli Lilly USD 10.01B 350.3M 2024-03
J&J USD 14.95B 148M 2024-03
Merck USD 11.37B 119M 2024-03
Novartis USD 8.25B 718M 2024-03
Pacira USD 101.64M 3.92M 2024-03
Perrigo USD 780M 11.9M 2024-03
Pfizer USD 15.22B 219M 2024-03
Prestige Brands USD 176.78M 2.49M 2024-03
Roche Holding CHF 11.36B 560M 2023-06
Supernus Pharmaceuticals USD 147.73M 3.58M 2024-03
Takeda JPY 743.08B 44.99B 2023-12
Teva Pharmaceutical Industries USD 3.46B 48M 2024-03
Zoetis USD 1.29B 11M 2024-03



Glaxosmithkline 应收帐款人 - 当前值，历史数据，预测，统计，图表和经济日历 - Jun 2024.